Skip to main content
Erschienen in: Clinical Journal of Gastroenterology 6/2019

27.05.2019 | Case Report

Neuroendocrine carcinoma of the esophagus with an adenocarcinoma component

verfasst von: Yuki Kaneko, Shin Saito, Kazuya Takahashi, Rihito Kanamaru, Yoshinori Hosoya, Hironori Yamaguchi, Joji Kitayama, Toshiro Niki, Alan Kawarai Lefor, Naohiro Sata

Erschienen in: Clinical Journal of Gastroenterology | Ausgabe 6/2019

Einloggen, um Zugang zu erhalten

Abstract

A 68-year-old male was referred with dysphagia. Endoscopic findings showed circular stenosis with a protruding mass in the lower esophagus. Biopsy showed adenocarcinoma and there was no evidence of distant metastases. A subtotal esophagectomy was performed. The resected specimen revealed a mixed neuroendocrine carcinoma with adenocarcinoma. The adenocarcinoma component was on the surface of the tumor and the neuroendocrine component invaded the deeper portion. Immunohistochemically, the neuroendocrine carcinoma component stained positive for cytokeratin 7 and cytokeratin 20, suggesting that the neuroendocrine carcinoma originated from the adenocarcinoma. The adenocarcinoma component stained positive for MUC2, which suggests that the adenocarcinoma component originated from Barrett’s epithelium. Taken together, the neuroendocrine carcinoma may have originated from Barrett’s epithelium. A metastasis to the liver was found 2 months after the surgical resection. Chemotherapy was administered, but there was no response. Most esophageal neuroendocrine carcinomas are accompanied by adenocarcinoma or squamous cell components, suggesting that these carcinomas originate from pluripotent cells in squamous or Barrett’s epithelium. Appropriate chemotherapy for these lesions should be considered based on the cell of origin.
Literatur
1.
Zurück zum Zitat Kitajima T, Kaida S, Lee S, et al. Mixed adeno (neuro) endocrine carcinoma arising from the ectopic gastric mucosa of the upper thoracic esophagus. World J Surg Oncol. 2013;11:218.CrossRef Kitajima T, Kaida S, Lee S, et al. Mixed adeno (neuro) endocrine carcinoma arising from the ectopic gastric mucosa of the upper thoracic esophagus. World J Surg Oncol. 2013;11:218.CrossRef
2.
Zurück zum Zitat Egashira A, Morita M, Kumagai R, et al. Neuroendocrine carcinoma of the esophagus: clinicopathological and immunohistochemical features of 14 cases. PLoS One. 2017;12:e0173501.CrossRef Egashira A, Morita M, Kumagai R, et al. Neuroendocrine carcinoma of the esophagus: clinicopathological and immunohistochemical features of 14 cases. PLoS One. 2017;12:e0173501.CrossRef
3.
Zurück zum Zitat Bosman FT, Carneiro F, Hruban RH, et al. WHO classification of tumours of the digestive system. 4th ed. International Agency for Research on Cancer. Lyon: IARC Press; 2010. Bosman FT, Carneiro F, Hruban RH, et al. WHO classification of tumours of the digestive system. 4th ed. International Agency for Research on Cancer. Lyon: IARC Press; 2010.
4.
Zurück zum Zitat Deng HY, Ni PZ, Wang YC, et al. Neuroendocrine carcinoma of the esophagus: clinical characteristics and prognostic evaluation of 49 cases with surgical resection. J Thorac Dis. 2016;8:1250–6.CrossRef Deng HY, Ni PZ, Wang YC, et al. Neuroendocrine carcinoma of the esophagus: clinical characteristics and prognostic evaluation of 49 cases with surgical resection. J Thorac Dis. 2016;8:1250–6.CrossRef
5.
Zurück zum Zitat Kadhim MM, Jespersen ML, Pilegaard HK, et al. Mixed adenoneuroendocrine carcinoma is a rare but important tumour found in the oesophagus. Case Rep Gastrointest Med. 2016;2016:9542687.PubMedPubMedCentral Kadhim MM, Jespersen ML, Pilegaard HK, et al. Mixed adenoneuroendocrine carcinoma is a rare but important tumour found in the oesophagus. Case Rep Gastrointest Med. 2016;2016:9542687.PubMedPubMedCentral
6.
Zurück zum Zitat Tustumi F, Takeda FR, Uema RH, et al. Primary neuroendocrine neoplasm of the esophagus—report of 14 cases from a single institute and review of the literature. Arq Gastroenterol. 2017;54:4–10.CrossRef Tustumi F, Takeda FR, Uema RH, et al. Primary neuroendocrine neoplasm of the esophagus—report of 14 cases from a single institute and review of the literature. Arq Gastroenterol. 2017;54:4–10.CrossRef
7.
Zurück zum Zitat Xiao X, Wang S, Xia S, et al. Retrospective study of irinotecan/cisplatin followed by etoposide/cisplatin or the reverse sequence in extensive-stage small cell lung tumor. OncoTargets Therapy. 2015;8:2209–14.CrossRef Xiao X, Wang S, Xia S, et al. Retrospective study of irinotecan/cisplatin followed by etoposide/cisplatin or the reverse sequence in extensive-stage small cell lung tumor. OncoTargets Therapy. 2015;8:2209–14.CrossRef
8.
Zurück zum Zitat Asayama M, Fuse N, Yoshino T, et al. Amrubicin for the treatment of neuroendocrine carcinoma of the gastrointestinal tract: a retrospective analysis of five cases. Cancer Chemother Pharmacol. 2011;68:1325–30.CrossRef Asayama M, Fuse N, Yoshino T, et al. Amrubicin for the treatment of neuroendocrine carcinoma of the gastrointestinal tract: a retrospective analysis of five cases. Cancer Chemother Pharmacol. 2011;68:1325–30.CrossRef
9.
Zurück zum Zitat Maru DM, Khurana H, Rashid A, et al. Retrospective study of clinicopathologic features and prognosis of high-grade neuroendocrine carcinoma of the esophagus. Am J Surg Pathol. 2008;32:1404–11.CrossRef Maru DM, Khurana H, Rashid A, et al. Retrospective study of clinicopathologic features and prognosis of high-grade neuroendocrine carcinoma of the esophagus. Am J Surg Pathol. 2008;32:1404–11.CrossRef
10.
Zurück zum Zitat Cary NR, Barron DJ, McGoldrick JP, et al. Combined oesophageal adenocarcinoma and carcinoid in Barrett’s oesophagitis: potential role of enterochromaffin-like cells in oesophageal malignancy. Thorax. 1993;48:404–5.CrossRef Cary NR, Barron DJ, McGoldrick JP, et al. Combined oesophageal adenocarcinoma and carcinoid in Barrett’s oesophagitis: potential role of enterochromaffin-like cells in oesophageal malignancy. Thorax. 1993;48:404–5.CrossRef
11.
Zurück zum Zitat McIntire MG, Soucy G, Vaughan TL, et al. MUC2 is a highly specific marker of goblet cell metaplasia in the distal esophagus and gastroesophageal junction. Am J Surg Pathol. 2011;35:1007–13.CrossRef McIntire MG, Soucy G, Vaughan TL, et al. MUC2 is a highly specific marker of goblet cell metaplasia in the distal esophagus and gastroesophageal junction. Am J Surg Pathol. 2011;35:1007–13.CrossRef
12.
Zurück zum Zitat Turkmen IC, Bassullu N, Uraz S, et al. CDX2, COX2 and MUC2 expressions in Barrett’s esophagus: can they be useful in determination of the dysplasia? Turk patoloji dergisi. 2012;28:251–8.PubMed Turkmen IC, Bassullu N, Uraz S, et al. CDX2, COX2 and MUC2 expressions in Barrett’s esophagus: can they be useful in determination of the dysplasia? Turk patoloji dergisi. 2012;28:251–8.PubMed
13.
Zurück zum Zitat Saint Martin MC, Chejfec G. Barrett esophagus-associated small cell carcinoma. Arch Pathol Lab Med. 1999;123:1123.PubMed Saint Martin MC, Chejfec G. Barrett esophagus-associated small cell carcinoma. Arch Pathol Lab Med. 1999;123:1123.PubMed
14.
Zurück zum Zitat Okuma HS, Iwasa S, Shoji H, et al. Irinotecan plus cisplatin in patients with extensive-disease poorly differentiated neuroendocrine carcinoma of the esophagus. Anticancer Res. 2014;34:5037–41.PubMed Okuma HS, Iwasa S, Shoji H, et al. Irinotecan plus cisplatin in patients with extensive-disease poorly differentiated neuroendocrine carcinoma of the esophagus. Anticancer Res. 2014;34:5037–41.PubMed
15.
Zurück zum Zitat Ando N, Kato H, Igaki H, et al. A randomized trial comparing postoperative adjuvant chemotherapy with cisplatin and 5-fluorouracil versus preoperative chemotherapy for localized advanced squamous cell carcinoma of the thoracic esophagus (JCOG9907). Ann Surg Oncol. 2012;19:68–74.CrossRef Ando N, Kato H, Igaki H, et al. A randomized trial comparing postoperative adjuvant chemotherapy with cisplatin and 5-fluorouracil versus preoperative chemotherapy for localized advanced squamous cell carcinoma of the thoracic esophagus (JCOG9907). Ann Surg Oncol. 2012;19:68–74.CrossRef
16.
Zurück zum Zitat Saif MW, Vethody C. Poorly differentiated neuroendocrine tumor of the esophagus with hypertrophic osteoarthropathy and brain metastasis: a success story. Cureus. 2016;8:646. Saif MW, Vethody C. Poorly differentiated neuroendocrine tumor of the esophagus with hypertrophic osteoarthropathy and brain metastasis: a success story. Cureus. 2016;8:646.
Metadaten
Titel
Neuroendocrine carcinoma of the esophagus with an adenocarcinoma component
verfasst von
Yuki Kaneko
Shin Saito
Kazuya Takahashi
Rihito Kanamaru
Yoshinori Hosoya
Hironori Yamaguchi
Joji Kitayama
Toshiro Niki
Alan Kawarai Lefor
Naohiro Sata
Publikationsdatum
27.05.2019
Verlag
Springer Japan
Erschienen in
Clinical Journal of Gastroenterology / Ausgabe 6/2019
Print ISSN: 1865-7257
Elektronische ISSN: 1865-7265
DOI
https://doi.org/10.1007/s12328-019-00995-7

Weitere Artikel der Ausgabe 6/2019

Clinical Journal of Gastroenterology 6/2019 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.